By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > General > Carbamazepine

Carbamazepine

GMJ
Last updated: 02/06/2026 14:30
By
Prof. Giorgi Pkhakadze
Share
5 Min Read
SHARE
3 min read|632 words

Carbamazepine: Uses, Side Effects, and Important Safety Information

What is Carbamazepine?

Carbamazepine is an anticonvulsant medication that belongs to a class of drugs called dibenzazepine derivatives. It is primarily used to treat epilepsy, certain types of nerve pain, and bipolar disorder. This medication has been widely prescribed since the 1960s and remains an important treatment option for several neurological and psychiatric conditions.

Uses

Carbamazepine has several FDA-approved uses and documented medical applications:

  • Epilepsy: Effective for treating partial seizures, generalized tonic-clonic seizures, and mixed seizure patterns in both adults and children
  • Trigeminal neuralgia: Considered a first-line treatment for this painful facial nerve condition that causes sharp, stabbing pain
  • Bipolar disorder: Used as a mood stabilizer to prevent manic and depressive episodes, particularly in patients who don’t respond well to lithium
  • Diabetic neuropathy: Sometimes prescribed off-label to manage nerve pain associated with diabetes
  • Glossopharyngeal neuralgia: Used to treat this rare condition causing severe throat and ear pain

How it works

Carbamazepine works by blocking sodium channels in nerve cells, which prevents the rapid firing of electrical impulses that can cause seizures or nerve pain. By stabilizing these electrical signals in the brain and nervous system, it helps control seizures and reduces abnormal nerve activity that leads to pain. The medication also affects neurotransmitter activity, which contributes to its mood-stabilizing effects in bipolar disorder.

Side effects

Common side effects include:

Submit Your Paper
GMJ_Submit_Banner
  • Dizziness and drowsiness
  • Nausea and vomiting
  • Headache
  • Blurred or double vision
  • Unsteadiness or coordination problems
  • Fatigue and weakness
  • Dry mouth
  • Constipation

Serious side effects to watch for:

  • Severe skin reactions including Stevens-Johnson syndrome
  • Blood disorders such as aplastic anemia or low white blood cell count
  • Liver problems or hepatitis
  • Heart rhythm abnormalities
  • Suicidal thoughts or behavior

Warnings and precautions

  • Genetic testing recommended: People of Asian descent should be tested for the HLA-B*1502 gene variant before starting carbamazepine, as they have a higher risk of serious skin reactions
  • Pregnancy considerations: Carbamazepine is classified as pregnancy category D, meaning it may cause harm to a developing fetus and should only be used when benefits outweigh risks
  • Blood monitoring required: Regular blood tests are necessary to monitor for blood disorders, liver function, and drug levels
  • Bone health: Long-term use may affect bone density and vitamin D metabolism, requiring monitoring and supplementation
  • Elderly patients: May be more sensitive to side effects and require lower doses or more frequent monitoring

Interactions

Carbamazepine has numerous important drug interactions due to its effects on liver enzymes:

  • Warfarin: Carbamazepine reduces warfarin effectiveness, requiring dose adjustments and closer INR monitoring
  • Oral contraceptives: Can reduce effectiveness of birth control pills, leading to breakthrough bleeding or unintended pregnancy
  • Other anticonvulsants: May interact with phenytoin, valproic acid, and lamotrigine, affecting blood levels of these medications
  • Antidepressants: Can reduce levels of tricyclic antidepressants and some SSRIs, potentially reducing their effectiveness
  • Grapefruit juice: May increase carbamazepine levels, leading to increased side effects
  • Erythromycin and clarithromycin: These antibiotics can significantly increase carbamazepine levels
  • St. John’s Wort: This herbal supplement can reduce carbamazepine effectiveness
  • Calcium channel blockers: Particularly verapamil and diltiazem, which can increase carbamazepine toxicity

Check interactions with the GMJ Interaction Checker

Dosage

Carbamazepine dosing varies significantly based on the condition being treated and individual patient factors. For epilepsy in adults, treatment typically begins with 200mg twice daily, gradually increasing to a maintenance dose of 800-1200mg daily divided into two or three doses. For trigeminal neuralgia, the starting dose is usually 100mg twice daily, increased gradually to 200-800mg daily as needed. Dosage should always be individualized and determined by a healthcare provider based on therapeutic response, side effects, and blood level monitoring.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Carbamazepine." GMJ News — Georgian Medical Journal, 2 June 2026. https://news.gmj.ge/drug/carbamazepine/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
U-shaped sleep curve reveals distinct aging patterns: short sleep drives aging, long sleep signals underlying disease

A Nature study of 500,000 UK adults reveals a U-shaped relationship between…

How Brew Time Transforms Tea Chemistry: What Science Reveals About Steeping Duration

Research mapping tea extraction kinetics reveals that steeping duration fundamentally alters the…

The Case for ‘Health Care’: Why Language Precision Matters in Medical Journalism

STAT News's recent reader poll found that approximately 60% of respondents prefer…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Magnesium supplements

By
Prof. Giorgi Pkhakadze
02/06/2026

Vortioxetine

By
Prof. Giorgi Pkhakadze
02/06/2026

Vitamin K2

By
Prof. Giorgi Pkhakadze
02/06/2026

Amphotericin B

By
Prof. Giorgi Pkhakadze
02/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up